These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
385 related articles for article (PubMed ID: 14530197)
21. Significance of valine/leucine247 polymorphism of beta2-glycoprotein I in antiphospholipid syndrome: increased reactivity of anti-beta2-glycoprotein I autoantibodies to the valine247 beta2-glycoprotein I variant. Yasuda S; Atsumi T; Matsuura E; Kaihara K; Yamamoto D; Ichikawa K; Koike T Arthritis Rheum; 2005 Jan; 52(1):212-8. PubMed ID: 15641049 [TBL] [Abstract][Full Text] [Related]
22. Binding of high-avidity anti-beta2-glycoprotein I antibodies. Cucnik S; Kveder T; Rozman B; Bozic B Rheumatology (Oxford); 2004 Nov; 43(11):1353-6. PubMed ID: 15280573 [TBL] [Abstract][Full Text] [Related]
24. Antiphospholipid reactivity against cardiolipin metabolites occurring during endothelial cell apoptosis. Alessandri C; Sorice M; Bombardieri M; Conigliaro P; Longo A; Garofalo T; Manganelli V; Conti F; Esposti MD; Valesini G Arthritis Res Ther; 2006; 8(6):R180. PubMed ID: 17150088 [TBL] [Abstract][Full Text] [Related]
25. High avidity anti-beta 2-glycoprotein I antibodies in patients with antiphospholipid syndrome. Cucnik S; Kveder T; Krizaj I; Rozman B; Bozic B Ann Rheum Dis; 2004 Nov; 63(11):1478-82. PubMed ID: 15479898 [TBL] [Abstract][Full Text] [Related]
26. Induction of anti-phospholipid autoantibodies by beta2-glycoprotein I bound to apoptotic thymocytes. Levine JS; Subang R; Koh JS; Rauch J J Autoimmun; 1998 Oct; 11(5):413-24. PubMed ID: 9802924 [TBL] [Abstract][Full Text] [Related]
27. [Anti-beta2 glycoprotein I-beta2 glycoprotein I] immune complexes in patients with antiphospholipid syndrome and other autoimmune diseases. Biasiolo A; Rampazzo P; Brocco T; Barbero F; Rosato A; Pengo V Lupus; 1999; 8(2):121-6. PubMed ID: 10192506 [TBL] [Abstract][Full Text] [Related]
28. beta 2-Glycoprotein I and anti-beta 2-glycoprotein I antibodies: where are we now? Inanç M; Radway-Bright EL; Isenberg DA Br J Rheumatol; 1997 Dec; 36(12):1247-57. PubMed ID: 9448584 [TBL] [Abstract][Full Text] [Related]
29. Pathogenic role of anti-beta 2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of beta 2-glycoprotein I binding to trophoblast cells and functional effects of anti-beta 2-glycoprotein I antibodies in vitro. Di Simone N; Raschi E; Testoni C; Castellani R; D'Asta M; Shi T; Krilis SA; Caruso A; Meroni PL Ann Rheum Dis; 2005 Mar; 64(3):462-7. PubMed ID: 15256379 [TBL] [Abstract][Full Text] [Related]
30. Enhancement of protein S anticoagulant function by beta2-glycoprotein I, a major target antigen of antiphospholipid antibodies: beta2-glycoprotein I interferes with binding of protein S to its plasma inhibitor, C4b-binding protein. Merrill JT; Zhang HW; Shen C; Butman BT; Jeffries EP; Lahita RG; Myones BL Thromb Haemost; 1999 May; 81(5):748-57. PubMed ID: 10365749 [TBL] [Abstract][Full Text] [Related]
32. Phospholipid-bound beta 2-glycoprotein I induces the production of anti-phospholipid antibodies. Subang R; Levine JS; Janoff AS; Davidson SM; Taraschi TF; Koike T; Minchey SR; Whiteside M; Tannenbaum M; Rauch J J Autoimmun; 2000 Aug; 15(1):21-32. PubMed ID: 10936025 [TBL] [Abstract][Full Text] [Related]
33. Characterization of estrogen-induced autoantibodies to cardiolipin in non-autoimmune mice. Verthelyi D; Ansar Ahmed S J Autoimmun; 1997 Apr; 10(2):115-25. PubMed ID: 9185873 [TBL] [Abstract][Full Text] [Related]
34. [Cardiolipin antibodies dependents on beta2-glycoprotein-1 in antiphospholipid syndrome]. Kuznetsova TV; Tishchenko VA; Kobylianskiĭ AG; Pal'keeva ME; Novikov AA; Reshetniak TM; Kliukvina NG; Nasonov EL Ter Arkh; 1999; 71(12):41-4. PubMed ID: 10647200 [TBL] [Abstract][Full Text] [Related]
35. The presence of anti-phosphatidylserine/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus. Nojima J; Iwatani Y; Suehisa E; Kuratsune H; Kanakura Y Haematologica; 2006 May; 91(5):699-702. PubMed ID: 16627257 [TBL] [Abstract][Full Text] [Related]
36. Monoclonal antibodies from NZW x BXSB F1 mice to beta2 glycoprotein I and cardiolipin. Species specificity and charge-dependent binding. Monestier M; Kandiah DA; Kouts S; Novick KE; Ong GL; Radic MZ; Krilis SA J Immunol; 1996 Apr; 156(7):2631-41. PubMed ID: 8786329 [TBL] [Abstract][Full Text] [Related]
37. Mechanisms of anti-phospholipid antibody formation and action. de Groot PG Thromb Res; 2011 Feb; 127 Suppl 3():S40-2. PubMed ID: 21262437 [TBL] [Abstract][Full Text] [Related]
38. Biotinylation of glycan chains in beta2 glycoprotein I induces dimerization of the molecule and its detection by the human autoimmune anti-cardiolipin antibody EY2C9. Dupuy D'Angeac A; Stefas I; Graafland H; De Lamotte F; Rucheton M; Palais C; Eriksson AK; Bosc P; Rosé C; Chicheportiche R Biochem J; 2006 Jan; 393(Pt 1):117-27. PubMed ID: 16097953 [TBL] [Abstract][Full Text] [Related]
39. Oxidation of beta2-glycoprotein I (beta2GPI) by the hydroxyl radical alters phospholipid binding and modulates recognition by anti-beta2GPI autoantibodies. Arvieux J; Regnault V; Hachulla E; Darnige L; Berthou F; Youinou P Thromb Haemost; 2001 Oct; 86(4):1070-6. PubMed ID: 11686326 [TBL] [Abstract][Full Text] [Related]
40. Beta2-glycoprotein I, anti-beta2-glycoprotein I, and fibrinolysis. Yasuda S; Atsumi T; Ieko M; Koike T Thromb Res; 2004; 114(5-6):461-5. PubMed ID: 15507279 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]